Global Nerve Repair Biomaterials Market to grow at the Highest CAGR of 11.5% – Analysis & Forecasts Report till 2024

Global Nerve Repair Biomaterials Market is expected to reach USD 775.59 million by 2024 from USD 326.71 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The nerve repair biomaterials market comprises of a few large and small players. The market is expected to witness competition in terms of new product launches, the introduction of new treatment options to meet changing customer requirements, and evolving industry standards in the forecast period 2017 to 2024. Integra LifeSciences Corporation dominated the nerve repair biomaterials market accounting for a highest market share in 2016, followed by Stryker and AxoGen, Inc. Other players in this market include Checkpoint Surgical, Inc., Collagen Matrix, Inc., Polyganics, B.V., and Synovis Micro Companies Alliance, Inc.26.3% of the global nerve repair biomaterials market in 2016.

Request For Sample: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nerve-repair-biomaterials-market

INTEGRA LIFESCIENCES CORPORATION

Founded in 1989 and headquartered in Plainsboro, New Jersey (U.S). Integra Lifesciences Corporation is engaged in the manufacturing and sales of medical instruments, devices, and equipment. It operates through the specialty surgical solutions, and orthopedics and tissue technologies segments. The specialty surgical solutions segment offers specialty surgical instrumentation for a broad range of specialties, such as products and solutions for dural repair, precision tools and instruments, tissue ablation, and neuro critical care.

Get Detailed Analysis of the Market @ http://databridgemarketresearch.com/reports/global-nerve-repair-biomaterials-market/

STRYKER:

Founded in 1941 and headquartered in Michigan, U.S., Stryker Corporation specializes in reconstructive, medical and surgical, and neurotechnology& spine products. The company has three business segments—orthopedic implants, medsurg, and neurotechnology and spine. The Medsurg segment focuses on surgical equipment, minimally invasive surgical solutions, sports medicine, and patient handling, and provides medical products for a variety of specialties.

Recent Developments:

• In April 2016, Stryker Corporation announced the completion of its previously announced acquisition of Synergetics USA, Inc.’s Neuro Portfolio.
Ask For An Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-nerve-repair-biomaterials-market

AXOGEN, INC.:

Incorporated in 1977 and headquartered in Alachua, Florida. AxoGen, Inc., is a regenerative medicine company, which is focused on science, development, and commercialization of technologies for peripheral nerve solutions. The company’s distribution channel extends from U.S., Canada, and many other countries either through direct distribution or through distributors. Some of the international partners through which AxoGen is operating outside North America are Crosstec GmbH, Anexxa Medical Technologies Inc., Fortis Technologies Ltd., MD For Life, Semenza Medical Solutions, Neutromedics and Hospital Innovations.

Inquire For TOC: http://databridgemarketresearch.com/toc/?dbmr=global-nerve-repair-biomaterials-market

Recent developments:

• In November 2016, AxoGen, Inc., announced the commercial release and first clinical implant of Avive Soft Tissue Membrane which is a minimally processed human umbilical cord membrane delivering the benefits of amnion to reduce inflammation and scar tissue formation.
• In March 2016, AxoGen, Inc., announced the commercial release and first sale of AcroVal Neurosensory & Motor Testing System (NSMTS) which is a nerve function evaluation solution for surgeons and other allied health professionals for electronically measuring, mapping, and monitoring patients with peripheral nerve injuries and conditions.

Nerve Repair Biomaterials Market Key Points:

Integra Life Sciences is going to dominate the injectable drug delivery market followed by Stryker Corporation and Collagen Matrix, Inc. along with others such asAxoGen, Inc., Checkpoint Surgical, Inc., Polyganics, and Synovis Micro Companies Alliance, Inc.
• Nerve Protection market is growing with the highest CAGR.
• Globally nerve grafts is driving the market with highest market share. However, a nerve conduit is growing with the highest CAGR.
• Epineural nerve repair is dominating the injury nerve repair biomaterials market.

Inquiry Before Buying: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nerve-repair-biomaterials-market

Table of Content:

1. INTRODUCTION
1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES
4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR
4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES
4.3.1.4. EXPANDED TARGET APPLICATIONS
4.3.2. RESTRAINTS
4.3.2.1. LACK OF PATIENT AWARENESS
4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS
4.3.3. OPPURTUNITIES
4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY
4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS
4.3.4. THREATS
4.3.4.1. DONOR SITE MORBIDITY
4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. NERVE REPAIR
6.2.1. NERVE CONDUITS
6.2.2. NERVE GRAFTS
6.2.2.1. ALLOGRAFTS
6.2.2.2. ACELLULARIZED ALLOGRAFTS
6.3. NERVE PROTECTION
6.3.1. NERVE PROTECTOR
6.3.2. NERVE WRAP
7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE
7.1. OVERVIEW
7.2. EPINEURAL NERVE REPAIR
7.3. PERINEURAL NERVE REPAIR
7.4. GROUP FASCICULAR NERVE REPAIR
8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER
8.1. OVERVIEW
8.2. HOSPITALS
8.3. AMBULATORY TRAUMA CENTERS
8.4. CLINICS
9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES
11.1. AXOGEN, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.6. DATA BRIDGE ANALYSIS
11.2. CHECKPOINT SURGICAL, INC.
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPEMENTS
11.2.6. DATA BRIDGE ANALYSIS
11.3. COLLAGEN MATRIX, INC.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4. INTEGRA LIFESCIENCES CORPORATION
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.6. DATA BRIDGE ANALYSIS
11.5. POLYGANICS B.V.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPEMENTS
11.5.6. DATA BRIDGE ANALYSIS
11.6. STRYKER CORPORATION
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.6. DATA BRIDGE ANALYSIS
11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Interventional Neurology Devices Market – Industry Trends and Forecast to 2024

Global Interventional Neurology Devices Market, By Product {(Aneurysm Coiling and Embolization Devices (Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices), Angioplasty Devices (Carotid Artery Stents, Embolic Protection Systems), Micro Support Devices (Microguidewires, Microcatheters), Neurothrombectomy Devices (CLOT Retrieval Devices, Suction and Aspiration Devices, Snares)},Procedure (Embolization, Angioplasty,Neurothrombectomy, Others), End-User (Hospitals, Neurology Clinics, Ambulatory Care Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America) – Industry Trends and Forecast to 2024

More Insights: http://databridgemarketresearch.com/reports/global-interventional-neurology-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor:investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.